Gladstone’s Melanie Ott and Alex Marson Elected to the National Academy of Medicine
Physician-scientists and directors at Gladstone Institutes, Ott and Marson are honored for their pioneering achievements in science and medicine.
Together with colleagues in clinical programs, we are investigating the relation between impairments in patients with brain disorders and in rodent models simulating these conditions. These studies aim to promote the development of suitable tests and novel treatment strategies to improve cognition and other neural functions in patients suffering from devastating diseases of the nervous system.

As a part of Gladstone, an independent nonprofit entity, the Behavioral Core offers prices that are lower than market and compare favorably with other service providers in the Bay Area. Recharge rates are based on the cost of services rendered.
For more information, contact Jeff Simms.
Projects are scheduled through iLab. Contact Jeff Simms to register for iLab.
Once a project is submitted, the core management team will schedule the desired assessments.
We offer nearly 70 different assessments covering diverse behavioral domains, including sensorimotor functions, emotional and social behaviors, and cognitive functions such as learning and memory.

Yes. The earlier we can meet with our users, the better. We find that when we’re involved in the early planning stages, we can help design studies that produce more robust and reproducible outcomes.
Projects can be initiated through iLab. Contact Jeff Simms to register for iLab and receive detailed instruction on project submission.
The core provides a complete service package, including data compilation and analysis. The data package is designed to be ready for publication and we provide support throughout the publication process.
We often work with researchers to adapt existing protocols or create novel paradigms to best answer individual research questions. These are often the most exciting and interesting projects for our team.
Li H, Guglielmetti C, Sei YJ, et al. (2023) Cell Reports. Apr 6;42(4):112335. doi: 10.1016/j.celrep.2023.112335.
Cho FS, Vainchtein ID, Voskobiynyk Y, et al. (2022) Sci Transl Med. Jul 6;14(652):eabj4310. doi: 10.1126/scitranslmed.abj4310.
Lin King YH, Chen C, Lin King JV, et al. (2022) PNAS. May 31;119(22):e2118240119. doi: 10.1073/pnas.2118240119.
Nguyen MK, McAvoy K, Liao SC, et al. (2022) Hum Mol Genet. May 4;31(9):1500-1518. doi: 10.1093/hmg/ddab329.
Shao E, Chang CW, Li Z et al. (2022) Sci Transl Med. Apr 27, 14(642) doi: 10.1126/scitranslmed.abm5527
Research in mice reveals how critical brain cells misfire in Alzheimer’s and identifies a targeted strategy to restore healthy brain rhythms.
Discover disease research, explore the latest scientific news, and connect with experts through Gladstone’s enriched digital platform.
The complex Rube Goldberg-like molecular machinery could inspire novel technology to study and treat disease.
Shipman is recognized for pioneering molecular technologies that record cellular activity, expand genome editing, and target antibiotic-resistant superbugs.
Our people are our most important asset. We offer a wide array of career opportunities both in our administrative offices and in our labs.
Open PositionsDiscoveries don’t stay in our labs. Gladstone facilitates spinout companies to advance promising therapies, shortening the path between scientific discovery and helping real patients.
Learn MoreYour gift to Gladstone will allow our researchers to pursue high-quality science, focus on disease, and train the next generation of scientific thought leaders.
Donate Now